Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg For adults with type 2 diabetes (T2D), along with diet and exercise to improve glycemic control, for adults with T2D and established CVD, to reduce risk of MACE (CV death, nonfatal MI, or nonfatal stroke), and for adults with T2D and chronic kidney disease, to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death
Flexible supply options : small orders for pilot studies or bulk/wholesale orders for labs and institutions seeking steady supply
If youve experienced unexpected side effects such as gastroparesis or vision loss after taking Ozempic or Wegovy, you may have legal options
Wegovy: A Powerful Weight Loss Drug for Adults with Obesity Wegovy (semaglutide injection 2.4 mg) is a higher-dose version of Ozempic, specifically approved for weight loss in adults with obesity or excess weight and at least one weight-related medical condition
This injectable medication mimics glucagon-like peptide-1 (GLP-1), a hormone that regulates appetite, metabolism, and energy balance